Online registration

Thank you for your interest in registering to the event

Investor Spotlight: Ridgeline Therapeutics – A Versant Ventures Discovery Engine

18. September 2019, 19:00 to 21:00

Halle 7, Gundeldingerfeld, Dornacherstrasse 192, 4053 Basel

Ridgeline Therapeutics is Versant’s newest discovery engine aimed at translating new opportunities from academics into industry quality therapeutic candidates. Based in Basel, this central European location allows for privileged access to both strong academic research as well as large pharmaceutical partners. Alex Mayweg will provide a deeper look into Ridgeline’s approach on company creation, drug discovery and portfolio successes. Participants will also learn about Ridgeline’s collaborations with academics and pharma companies.

 

When: 18.09.2019, 19:00 - 21:00

Where: Halle 7, Gundeldingerfeld, Dornacherstrasse 192, 4053 Basel

 

Program:

18:30

Door Opening

19:00

Introduction

19:05

Dr. Alex Mayweg, President of Ridgeline Therapeutics, Partner at Versant Ventures

19:35

Q&A

20:00

Networking Apero

 


Participation to the event is free of charge; however, your registration by 16th September 2019 is kindly required.
 

Your personal information:

Salutation *
  •  
  • * Required fields

    Please fill in all required fields.

  • continuecontinue

Summary

Name
Email:
Company:
Street:
ZIP:
City:

Please provide the email address to which we should send the confirmation email:

  • backback
  • * Required fields

    Please fill in all required fields.

Your data is processed.

Please wait for the confirmation page.

Der Zeitbedarf für das Hochladen der gewählten Dateien mit einer Größe von insgesamt {$CurrentTotalFileSize} wird mit ca. {$FileUploadEstimatedUploadTime} abgeschätzt.